The resolution of inflammation

Nature Reviews Immunology

Volumn 13, Issue 1, 2013, Pages 59-66

  Buckley, Christopher D ^a   Gilroy, Derek W ^b   Serhan, Charles N ^c   Stockinger, Brigitta ^d   Tak, Paul P ^e,f  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (United Kingdom)

^e GLAXOSMITHKLINE   (United Kingdom)

^f UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE; INTERLEUKIN 10; LIPOXIN; NITRIC OXIDE; PROSTAGLANDIN; STEROID; TOLL LIKE RECEPTOR;

ANTIINFLAMMATORY ACTIVITY; AUTOIMMUNITY; CELL INTERACTION; EXUDATE; HOMEOSTASIS; HUMAN; IMMUNOLOGICAL MEMORY; INFLAMMATION; INNATE IMMUNITY; MEDIATOR; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; REVIEW; TH1 CELL; TH17 CELL; TISSUE REPAIR;

ANIMALS; HUMANS; IMMUNITY, INNATE; INFLAMMATION; INFLAMMATION MEDIATORS; LEUKOCYTES; MACROPHAGES; SIGNAL TRANSDUCTION;

EID: 84871509601     PISSN: 14741733     EISSN: 14741741     Source Type: Journal    
DOI: 10.1038/nri3362     Document Type: Review

References (61)

1. Gilroy, D. W., Lawrence, T., Perretti, M. & Rossi, A. G. Inflammatory resolution: new opportunities for drug discovery. Nature Rev. Drug Discov. 3, 401-416 (2004).
2. Serhan, C. N. et al. Resolvins: a family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals. J. Exp. Med. 196, 1025-1037 (2002).
3. Gilroy, D. W. & Perretti, M. Aspirin and steroids: new mechanistic findings and avenues for drug discovery. Curr. Opin. Pharmacol. 5, 405-411 (2005).
4. Serhan, C. N. & Savill, J. Resolution of inflammation: the beginning programs the end. Nature Immunol. 6, 1191-1197 (2005).
5. Serhan, C. N. A search for endogenous mechanisms of anti-inflammation uncovers novel chemical mediators: missing links to resolution. Histochem. Cell Biol. 122, 305-321 (2004).
6. Frazier, W. J. et al. Increased inflammation, impaired bacterial clearance, and metabolic disruption after Gram-negative sepsis in Mkp-1-deficient mice. J. Immunol. 183, 7411-7419 (2009).
7. Olofsson, P. S., Rosas-Ballina, M., Levine, Y. A. & Tracey, K. J. Rethinking inflammation: neural circuits in the regulation of immunity. Immunol. Rev. 248, 188-204 (2012).
8. Metchnikoff, E. Immunity in Infective Diseases (Cambridge Univ. Press, 1905).
9. Tauber, A. I. & Chernyak, L. Metchnikoff and the Origins of Immunology: From Metaphor to Theory (Oxford Univ. Press, 1991).
10. Savill, J. S., Henson, P. M. & Haslett, C. Phagocytosis of aged human neutrophils by macrophages is mediated by a novel "charge-sensitive" recognition mechanism. J. Clin. Invest. 84, 1518-1527 (1989).
11. Serhan, C. N. et al. Novel functional sets of lipid-derived mediators with antiinflammatory actions generated from omega-3 fatty acids via cyclooxygenase 2-nonsteroidal antiinflammatory drugs and transcellular processing. J. Exp. Med. 192, 1197-1204 (2000).
12. Serhan, C. N. et al. Macrophage pro-resolving mediator maresin 1 stimulates tissue regeneration and controls pain. FASEB J. 26, 1755-1765 (2012).
13. Serhan, C. N. et al. Resolution of inflammation: state of the art, definitions and terms. FASEB J. 21, 325-332 (2007).
14. Mitchell, S. et al. Lipoxins, aspirin-triggered epi-lipoxins, lipoxin stable analogues, and the resolution of inflammation: stimulation of macrophage phagocytosis of apoptotic neutrophils in vivo. J. Am. Soc. Nephrol. 13, 2497-2507 (2002).
15. Lawrence, T., Gilroy, D. W., Colville-Nash, P. R. & Willoughby, D. A. Possible new role for NF-κB in the resolution of inflammation. Nature Med. 7, 1291-1297 (2001).
16. Hyman, M. C. et al. Self-regulation of inflammatory cell trafficking in mice by the leukocyte surface apyrase CD39. J. Clin. Invest. 119, 1136-1149 (2009).
17. Majno, G. & Joris, I. Cells, Tissues and Disease: Principles of General Pathology (Blackwell Science, 1996).
18. Yamada, T. et al. Eosinophils promote resolution of acute periotonitis by producing proresolving mediators in mice. FASEB J. 25, 561-568 (2011).
19. Haworth, O., Cernadas, M., Yang, R., Serhan, C. N. & Levy, B. D. Resolvin E1 regulates interleukin 23, interferon-γ and lipoxin A4 to promote the resolution of allergic airway inflammation. Nature Immunol. 9, 873-879 (2008).
20. H2 skewing and promotes human T cell apoptosis via lipid raft clustering. J. Biol. Chem. 280, 43079-43086 (2005).
21. Chiang, N. et al. Infection regulates pro-resolving mediators that lower antibiotic requirements. Nature 484, 524-528 (2012).
22. Uderhardt, S. et al. 12/15-lipoxygenase orchestrates the clearance of apoptotic cells and maintains immunologic tolerance. Immunity 36, 834-846 (2012).
23. Rajakariar, R. et al. Novel biphasic role for lymphocytes revealed during resolving inflammation. Blood 111, 4184-4192 (2008).
24. Didierlaurent, A. et al. Sustained desensitization to bacterial Toll-like receptor ligands after resolution of respiratory influenza infection. J. Exp. Med. 205, 323-329 (2008).
25. Duffield, J. S. et al. Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair. J. Clin. Invest. 115, 56-65 (2005).
26. Stables, M. J. et al. Transcriptomic analyses of murine resolution-phase macrophages. Blood 118, e192-e208 (2012).
27. Fang, Y., Sharp, G. C., Yagita, H. & Braley-Mullen, H. A critical role for TRAIL in resolution of granulomatous experimental autoimmune thyroiditis. J. Pathol. 216, 505-513 (2008).
28. Buckley, C. D. et al. Fibroblasts regulate the switch from acute resolving to chronic persistent inflammation. Trends Immunol. 22, 199-204 (2001).
29. Parsonage, G. et al. A stromal address code defined by fibroblasts. Trends Immunol. 26, 150-156 (2005).
30. - entheseal resident T cells. Nature Med. 18, 1069-1076 (2012).
31. van Maanen, M. A., Stoof, S. P., Larosa, G. J., Vervoordeldonk, M. J. & Tak, P. P. Role of the cholinergic nervous system in rheumatoid arthritis: aggravation of arthritis in nicotinic acetylcholine receptor α7 subunit gene knockout mice. Ann. Rheum. Dis. 69, 1717-1723 (2010).
32. Cutolo, M., Foppiani, L. & Minuto, F. Hypothalamic-pituitary-adrenal axis impairment in the pathogenesis of rheumatoid arthritis and polymyalgia rheumatica. J. Endocrinol. Invest. 25, 19-23 (2002).
33. McGettrick, H. M., Butler, L. M., Buckley, C. D., Rainger, G. E. & Nash, G. B. Tissue stroma as a regulator of leukocyte recruitment in inflammation. J. Leukoc. Biol. 91, 385-400 (2012).
34. Tak, P. P., Zvaifler, N. J., Green, D. R. & Firestein, G. S. Rheumatoid arthritis and p53: how oxidative stress might alter the course of inflammatory diseases. Immunol. Today 21, 78-82 (2000).
35. Murdoch, J. R. & Lloyd, C. M. Resolution of allergic airway inflammation and airway hyperreactivity is mediated by IL-17-producing γδ T cells. Am. J. Respir. Crit. Care Med. 182, 464-476 (2010).
36. H17 cell differentiation. Nature 458, 78-82 (2009).
37. Segal, A. W., Geisow, M., Garcia, R., Harper, A. & Miller, R. The respiratory burst of phagocytic cells is associated with a rise in vacuolar pH. Nature 290, 406-409 (1981).
38. Pollock, J. D. et al. Mouse model of X-linked chronic granulomatous disease, an inherited defect in phagocyte superoxide production. Nature Genet. 9, 202-209 (1995).
39. Calabro, S. et al. Vaccine adjuvants alum and MF59 induce rapid recruitment of neutrophils and monocytes that participate in antigen transport to draining lymph nodes. Vaccine 29, 1812-1823 (2011).
40. Dadabhoy, D. & Clauw, D. J. Therapy insight: fibromyalgia\a different type of pain needing a different type of treatment. Nature Clin. Pract. Rheumatol. 2, 364-372 (2006).
41. Brittijn, S. A. et al. Zebrafish development and regeneration: new tools for biomedical research. Int. J. Dev. Biol. 53, 835-850 (2009).
42. Chapple, I. L., Socransky, S. S., Dibart, S., Glenwright, H. D. & Matthews, J. B. Chemiluminescent assay of alkaline phosphatase in human gingival crevicular fluid: investigations with an experimental gingivitis model and studies on the source of the enzyme within crevicular fluid. J. Clin. Periodontol. 23, 587-594 (1996).
43. Chan, M. M.-Y. & Moore, A. R. Resolution of inflammation in murine autoimmune arthritis is disrupted by cyclooxygenase-2 inhibition and restored by prostaglandin E2-mediated lipoxin A4 production. J. Immunol. 184, 6418-6426 (2010).
44. Gilroy, D. W. et al. Inducible cyclooxygenase may have anti-inflammatory properties. Nature Med. 5, 698-701 (1999).
45. Bannenberg, G. L. et al. Molecular circuits of resolution: formation and actions of resolvins and protectins. J. Immunol. 174, 4345-4355 (2005).
46. Navarro-Xavier, R. A. et al. A new strategy for the identification of novel molecules with targeted proresolution of inflammation properties. J. Immunol. 184, 1516-1525 (2010).
47. Pillai, P. S. et al. Chemical mediators of inflammation and resolution in post-operative abdominal aortic aneurysm patients. Inflammation 35, 98-113 (2012).
48. Mulero, V., Sepulcre, M. P., Rainger, G. E. & Buckley, C. D. Editorial: neutrophils live on a two-way street. J. Leukoc. Biol. 89, 645-647 (2011).
49. NULL mice. Am. J. Pathol. 181, 74-84 (2012).
50. Perretti, M. et al. Endogenous lipid-and peptide-derived anti-inflammatory pathways generated with gluco-corticoid and aspirin treatment activate the lipoxin A4 receptor. Nature Med. 8, 1296-1302 (2002).
51. Rossi, A. G. et al. Cyclin-dependent kinase inhibitors enhance the resolution of inflammation by promoting inflammatory cell apoptosis. Nature Med. 12, 1056-1064 (2006).
52. Burstein, S. H., McQuain, C. A., Ross, A. H., Salmonsen, R. A. & Zurier, R. E. Resolution of inflammation by N-arachidonoylglycine. J. Cell. Biochem. 112, 3227-3233 (2011).
53. Yanes, O. et al. Metabolic oxidation regulates embryonic stem cell differentiation. Nature Chem. Biol. 6, 411-417 (2010).
54. Gerlag, D. M. et al. EULAR recommendations for terminology and research in individuals at risk of rheumatoid arthritis: report from the Study Group for Risk Factors for Rheumatoid Arthritis. Ann. Rheum. Dis. 71, 638-641 (2012).
55. Serezani, C. H. et al. Prostaglandin E2 suppresses bacterial killing in alveolar macrophages by inhibiting NADPH oxidase. Am. J. Respir. Cell Mol. Biol. 37, 562-570 (2007).
56. Aronoff, D. M., Canetti, C. & Peters-Golden, M. Prostaglandin E2 inhibits alveolar macrophage phagocytosis through an E-prostanoid 2 receptor-mediated increase in intracellular cyclic AMP. J. Immunol. 173, 559-565 (2004).
57. Stables, M. J. et al. Priming innate immune responses to infection by cyclooxygenase inhibition kills antibiotic-susceptible and-resistant bacteria. Blood 116, 2950-2959 (2010).
58. Aronoff, D. M. et al. E-prostanoid 3 receptor deletion improves pulmonary host defense and protects mice from death in severe Streptococcus pneumoniae infection. J. Immunol. 183, 2642-2649 (2009).
59. Spite, M. et al. Resolvin D2 is a potent regulator of leukocytes and controls microbial sepsis. Nature 461, 1287-1291 (2009).
60. Seki, H. et al. The anti-inflammatory and proresolving mediator resolvin E1 protects mice from bacterial pneumonia and acute lung injury. J. Immunol. 184, 836-843 (2010).
61. 4 in topical treatment of infantile eczema. Br. J. Dermatol. 27 Jul 2012 (doi:10.1111/j.1365-2133.2012.11177.x).